ClinicalTrials.gg
RecruitingNCT07756905Updated Aug 11, 2026

Effect of Somatosensory Motor Control With and Without Kinesio Tape in Patients With Sciatica

An interventional study of somatosensory motor control exercises, Kinesiology taping, and conventional Treatment and somatosensory motor control and conventional Treatment in Sciatica, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 35 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Jun 2025, registered Jul 2026).
  • Started Jun 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
35 Years to 50 Years
Sex
All
01

Study summary

Sciatica can be defined as a radicular pain that runs through the sciatic nerve from the lower back to the lower limbs and also may be associated with weakness or numbness in the muscles. These symptoms may affect proprioception, dynamic balance and functional mobility, which result in limitations of activity and disability. Training to improve somatosensory motor control has been shown to be effective in improving coordination and postural stability and Kinesio taping has the potential to increase proprioceptive input, decrease pain and aid functional recovery.

Read the detailed description

To evaluate the additional effects of kinesio taping when added to somatosensory motor control training on pain, active range of motion of the lumbar spine, proprioceptive related postural control, dynamic balance and functional disability in people with discogenic sciatica.

The study was an accessor-blinded randomized controlled trial approved by the ethical council of Riphah College of Rehabilitation \& Allied Health Sciences and was carried out for 11 months in 4 hospitals at Sialkot. 58 Participants were randomized; among which 54 participants completed the intervention and were included in per-protocol analysis with 27 participants in each group. During the 6-week intervention period, Group A was administered with somatosensory motor control training, conventional therapy, and Kinesio taping; while Group B was administered with the same intervention with the exception of Kinesio taping. The following outcome measures were used: Visual Analog Scale, Oswestry Disability Index, Modified Schober Test, Y-Balance Test, Romberg Test, and Tandem Stand Test. Data was analyzed in SPSS version 25 with statistical significance being considered as p\<0.05.

02

Conditions studied

  • Sciatica

Browse trials for

Keywords

  • Pain
  • Lumbar Range of Motion
  • Dynamic Balance
  • Functional Disability
03

In context

Sciatica

149 studies on the registry are indexed under Sciatica; 31 are open to participants now.

This study's planned enrollment of 58 is below the median of 68 across 122 interventional studies indexed under Sciatica.

Browse Sciatica studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Both male and females.

      • Age between 35-50 years.
      • Discogenic pain due to Diagnosed herniation lumbar disc L4/L5 and L5/S1 (confirmed by MRI).
      • unilateral leg pain radiating below the knee accompanied by numbness, tingling, or weakness in the affected leg.
      • Pain persists between 3-6 months.
      • Positive Straight Leg Raise (SLR) test between 40° to 70°, suggestive of neural irritation.

Exclusion criteria

Exclusion Criteria:

    • Patients with inflammatory diseases like ankylosing spondylitis, vertebral collapse, rheumatoid arthritis, stenosis, spondylolisthesis, or osteoporosis.

      • Recent spinal surgery
      • Abdominal or lower limb surgery
      • Pregnancy
      • Skin allergies
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
58 participants (estimated)

Study arms

  • Experimental
    Group A

    somatosensory motor control (include PNF, somatosensory exercises and vestibular exercises) + Kinesiology taping+ conventional Treatment Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks Assessment Points: Pre-treatment (Baseline) Post-treatment (End of 6th week)

    Other: somatosensory motor control exercises, Kinesiology taping, and conventional Treatment

  • Active comparator
    Group B

    somatosensory motor control (include PNF, somatosensory exercises and vestibular exercises) + conventional Treatment Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks Assessment Points: Pre-treatment (Baseline) Post-treatment (End of 6th week)

    Other: somatosensory motor control and conventional Treatment

Interventions

  • Othersomatosensory motor control exercises, Kinesiology taping, and conventional Treatment

    Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks Assessment Points: Pre-treatment (Baseline) Post-treatment (End of 6th week)

  • Othersomatosensory motor control and conventional Treatment

    Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks Assessment Points: Pre-treatment (Baseline) Post-treatment (End of 6th week)

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale

    The Visual Analogue Scale (VAS) is scored by measuring the distance in millimeters (from 0 to 100 mm) or centimeters (0 to 10 cm) on a straight line between the "no pain" anchor and the patient's mark. Higher numbers mean more intense symptoms.

    Time frame: Baseline and post 6 weeks

  2. lumbar range of motion

    Modified Schober Test, The Schober Test evaluates lower back movement. Scoring is based on how much the distance between marked points on the spine increases during forward bending. A starting 15 cm span should stretch to 20 cm or more; an increase under 5 cm shows reduced flexibility

    Time frame: Baseline and post 6 weeks

  3. dynamic balance

    Y balance test, The Y Balance Test is a standardized three-direction reach test (anterior, posteromedial, posterolateral) used to assess dynamic balance, limb asymmetry, and injury risk, with anterior reach asymmetry \>4 cm and composite scores below \~89-94% linked to higher injury risk.

    Time frame: Baseline and post 6 weeks

  4. functional disability

    Oswestry Disability Index (ODI), The Oswestry Disability Index (ODI) is a 10-item patient questionnaire scored from 0 to 5 per question. Total the points, divide by the maximum possible score (usually 50, or 5 × questions answered), and multiply by 100 to get a percentage score from 0% to 100%. You can calculate scores interactively using tools like OrthoToolKit.

    Time frame: Baseline and post 6 weeks

07

Study locations

1 of 1 sites recruiting
  • Civil hospital Sialkot
    Sialkot, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07756905
Responsible party
Sponsor
First posted
Aug 11, 2026
Start date
Jun 1, 2025
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Aug 11, 2026

Study contacts

Imran Amjad, PhD
Contact
imran.amjad@riphah.edu.pk
03324390125
Aiza Yousaf, MSOMPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion